Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy
Yuebao Zhang(The Ohio State University), Yizhou Dong(Allen Institute for Brain Science), Jinyue Yan(KTH Royal Institute of Technology), Xucheng Hou(Allen Institute for Brain Science), Binbin Deng(The Ohio State University), Yonger Xue(Allen Institute for Brain Science), Chang Wang(Allen Institute for Brain Science), Yichen Zhong(Allen Institute for Brain Science), Diana D. Kang(The Ohio State University), Shi Du(Hodges University), David W. McComb(The Ohio State University)
Cited by 107
Related Papers
Lipid nanoparticles for mRNA delivery
|Nature Reviews Materials|2021|3.5k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Lipids and Lipid Derivatives for RNA Delivery
|Chemical Reviews|2021|592
Large-Area, Flexible, Transparent, and Long-Lived Polymer-Based Phosphorescence Films
|Journal of the American Chemical Society|2021|513
Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA)
|The American Journal of Surgical Pathology|2008|346